Parent-Mediated Intervention Beneficial for Toddlers Who Are Deaf
By Elana Gotkine HealthDay Reporter
TUESDAY, May 27, 2025 -- A parent-mediated intervention (PMI) is beneficial for child communication outcomes in children who are deaf or hard of hearing (DHH), according to a study published online May 27 in Pediatrics.
Maranda K. Jones, Ph.D., from the School of Communication at Northwestern University in Evanston, Illinois, and colleagues conducted a single-site parallel stratified clinical trial enrolling 96 parent-child dyads. Children were aged 12 to 18 months old, had been diagnosed with bilateral hearing loss without additional diagnoses, had at least one parent with typical hearing, and were exposed to some degree of spoken language by their parents. The mode of communication was measured as exposure or no exposure to sign. Dyads were randomly allocated to the PMI, which occurred weekly via telehealth over six months, or a control group.
The researchers found that participants in the PMI group had greater parent strategy use (Cohen's d = 1.57) and child communication (Cohen's d = 0.59), indicating a statistically and clinically significant intervention effect. Compared with children not exposed to signs, the intervention effect on child communication was significantly greater for children exposed to signs (regression coefficient = 18.93).
"The current study is a first step toward the implementation of evidence-based early communication interventions designed to maximize language outcomes for DHH children," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
AAP Updates Screening Guidance for Child Mental Health, Behavioral Problems
MONDAY, Aug. 25, 2025 -- In a clinical report issued by the American Academy of Pediatrics and published online Aug. 25 in Pediatrics, updated recommendations are presented for...
Discordance Seen Between Care Goals, Treatment Intent in Advanced Cancer
MONDAY, Aug. 25, 2025 -- More patients with advanced cancer report that their treatment discordantly focuses on longevity over comfort than patients with other illnesses...
Apitegromab Improves Motor Function in Spinal Muscular Atrophy
MONDAY, Aug. 25, 2025 -- For patients with nonambulatory type 2 or type 3 spinal muscular atrophy, apitegromab, a monoclonal antibody that inhibits myostatin activation, improves...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.